The Lancet Neurology in conversation with
A podcast by The Lancet Group - Thursdays

Categories:
187 Episodes
-
Giuseppe Citerio on frailty and TBI
Published: 1/19/2022 -
Alberto Costa on memantine in adolescents and young adults with Down syndrome
Published: 12/20/2021 -
Olivier Rascol on amantadine for patients with movement disorders
Published: 11/17/2021 -
Antonio Uccelli on stems cells for MS
Published: 10/20/2021 -
Priya Palta on blood pressure control and cognitive decline
Published: 9/15/2021 -
Adam Boxer on tau biomarkers
Published: 8/18/2021 -
Irene Cortese on the difficulties of designing clinical trials
Published: 7/21/2021 -
Doug Turnbull on mitochondrial diseases in adults
Published: 6/16/2021 -
Geert Jan Biessels on predicting post-stroke cognitive impairment
Published: 5/19/2021 -
Henk-Jan Westeneng on the causal effects of pre-symptomatic lifestyle on ALS
Published: 4/21/2021 -
Anne MacGregor on menstrual migraine
Published: 3/17/2021 -
Peter Rothwell on asymptomatic carotid stenosis and stroke
Published: 2/17/2021 -
Spinal cord injury and degenerative cervical myelopathy
Published: 1/20/2021 -
Genetic risk factors for sCJD
Published: 12/22/2020 -
Prednisone in short-term prevention of cluster headache
Published: 11/24/2020 -
PET imaging of inflammation in neurological and psychiatric disorders
Published: 10/21/2020 -
Neurological associations of COVID-19
Published: 9/4/2020 -
Advances in understanding of Rett syndrome
Published: 7/31/2020 -
Management of Parkinson's disease
Published: 6/17/2020 -
Optimal time to treat Huntington's Disease
Published: 5/26/2020
Editors at The Lancet Neurology, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.
A monthly audio companion to the journal, this podcast covers a broad range of topics, from sleep habits to amyloid biomarkers in Alzheimer’s, the diagnosis and classification of optic neuritis to treatment of Creutzfeldt-Jakob disease, and more.